Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial
Dion Morton, Matthew Seymour, Laura Magill et al. · Journal of Clinical Oncology · 2023 · Randomised trial
Full textCC BY
Oncology
Filters3 filters applied
Status
Year
Readable here
Study type
12 papers1 CorrectedQuestions on this topic
Corrected First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial
Karim Fizazi, Arun A. Azad, Nobuaki Matsubara et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Lacey J. Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · Randomised trial
Full textCC BY
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
Robert H. I. Andtbacka, Frances Collichio, Kevin J. Harrington et al. · Journal for ImmunoTherapy of Cancer · 2019 · Randomised trial
Full textCC BY
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
Yago Pico de Coaña, Maria Wolodarski, Isabel Poschke et al. · Oncotarget · 2017 · Randomised trial
Full textCC BY
Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
for the Dutch Pancreatic Cancer Group (DPCG), Eva Versteijne, Casper H. J. van Eijck et al. · Trials · 2016 · Randomised trial
Full textCC BY
A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
Sanjeev Krishna, Senthil Ganapathi, Irina Chis Ster et al. · EBioMedicine · 2015 · Randomised trial
Full textCC BY
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
Matthew T Seymour, Sarah R Brown, Gary Middleton et al. · The Lancet Oncology · 2013 · Randomised trial
Full textCC BY
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
Per J Nilsson, Boudewijn van Etten, Geke AP Hospers et al. · BMC Cancer · 2013 · Randomised trial
Full textCC BY
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Gareth J Morgan, J Anthony Child, Walter M Gregory et al. · The Lancet Oncology · 2011 · Randomised trial
Full textCC BY
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
L Hol, J A Wilschut, M van Ballegooijen et al. · British Journal of Cancer · 2009 · Randomised trial
Full textCC BY
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
on Behalf of the Japan Clinical Oncology Group (JCOG)-Lung Cancer Study Group, H Okamoto, K Watanabe et al. · British Journal of Cancer · 2007 · Randomised trial
Full textCC BY